| Literature DB >> 32584397 |
Juncal Roca-Ginés1, Ignacio Torres-Navarro1, Javier Sánchez-Arráez1, Carlos Abril-Pérez1, Oihana Sabalza-Baztán2, Sergio Pardo-Granell2, Vicent Martínez I Cózar3, Rafael Botella-Estrada1,4, Montserrat Évole-Buselli1.
Abstract
Importance: A novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has recently been identified as the cause of a pandemic called coronavirus disease 2019 (COVID-19). In this context, some associated skin diseases have been described. Cutaneous lesions referred to as acute acro-ischemia have been reported as a possible sign of COVID-19 in adolescents and children. Objective: To evaluate the pathogenesis of these newly described acute acral lesions. Design, Setting, and Participants: This prospective case series was conducted at La Fe University Hospital, a tertiary referral hospital in Valencia, Spain, between April 9 and April 15, 2020. Among 32 referred patients, 20 children and adolescents with new-onset inflammatory lesions did not have a diagnosis. Exposures: Patients were not exposed to any drug or other intervention. Main Outcomes and Measures: We performed reverse transcriptase-polymerase chain reaction for SARS-CoV-2 and a range of blood tests for possible origins of the lesions. Skin biopsies were performed in 6 patients.Entities:
Mesh:
Year: 2020 PMID: 32584397 PMCID: PMC7317654 DOI: 10.1001/jamadermatol.2020.2340
Source DB: PubMed Journal: JAMA Dermatol ISSN: 2168-6068 Impact factor: 10.282
Main Characteristics of the Patients
| Patient No. | Sex | PAVR | Wears shoes at home | Heat in home | Co-inhabitants with similar symptoms | Disease duration before consultation, d | Location of skin lesions | Type of acral lesions | Histopathologic findings | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Epidermal changes | Dermal changes | Infiltrate allocation | |||||||||
| 1 | M | Yes | Yes | No | No | 7 | Feet | AE | Scattered NKA | Endothelial swelling | Papillary dermis |
| Spongiosis | PV | ||||||||||
| Mild VC | PE | ||||||||||
| 2 | F | Yes | No | No | Yes | 30 | Hands | D | NP | NP | NP |
| 3 | F | Yes | Yes | No | No | 9 | Hands and feet | MP (D, PMP) | NP | NP | NP |
| 4 | M | Yes | Yes | No | No | 26 | Hands and feet | D | NP | NP | NP |
| 5 | M | Yes | Yes | No | No | 21 | Feet | PMP | Abundant NKA | Endothelial swelling | Papillary dermis |
| Spongiosis | Lymphocytic vasculitis | PV | |||||||||
| Severe VC | Fibrin deposition | PE | |||||||||
| Moderate edema | |||||||||||
| 6 | F | Yes | Yes | No | No | 10 | Feet | D | NP | NP | NP |
| 7 | M | No | Yes | No | No | 10 | Feet | D | NP | NP | NP |
| 8 | F | Yes | Yes | No | No | 10 | Feet | PMP | Abundant NKA | Endothelial swelling | Papillary dermis |
| Spongiosis | Lymphocytic vasculitis | PV | |||||||||
| Severe VC | Fibrin deposition | PE | |||||||||
| Moderate edema | |||||||||||
| 9 | M | No | Yes | No | Yes | 17 | Feet | PMP | NP | NP | NP |
| 10 | F | No | No | No | Yes | 7 | Feet | MP | NP | NP | NP |
| 11 | M | No | Yes | No | No | 10 | Feet | PMP | Mild NKA | Endothelial swelling | Papillary dermis |
| Spongiosis | Dermal thrombi | PV | |||||||||
| Mild VC | PE | ||||||||||
| 12 | M | No | Yes | No | No | 30 | Feet | PMP | NP | NP | NP |
| 13 | M | No | No | Yes | No | 10 | Hands and feet | AE | NP | NP | NP |
| 14 | M | No | Yes | No | No | 3 | Feet | AE | NP | NP | NP |
| 15 | M | No | No | No | Yes | 7 | Feet | MP | NP | NP | NP |
| 16 | M | No | Yes | Yes | No | 7 | Feet | PMP | Mild NKA | Endothelial swelling | Papillary dermis |
| Spongiosis | Lymphocytic vasculitis | PV | |||||||||
| Severe VC | Moderate edema | PE | |||||||||
| 17 | F | Yes | Yes | No | No | 4 | Hands and feet | AE | NP | NP | NP |
| 18 | F | No | No | No | Yes | 14 | Hands | AE | NP | NP | NP |
| 19 | M | Yes | Yes | No | Yes | 14 | Feet | AE | NP | NP | NP |
| 20 | M | No | Yes | No | No | 19 | Feet | PMP | Abundant NKA | Endothelial swelling | Papillary dermis |
| Spongiosis | Fibrin deposition | PV | |||||||||
| Mild VC | Dermal thrombi | PE | |||||||||
Abbreviations: AE, acral erythema; D, dactylitis; MP, mixed pattern; NKA, necrotic keratinocytes; NP, not performed; PAVR, previous acral vascular reactivity; PE, perieccrine; PMP, purpuric maculopapules; PV, perivascular; VC, vacuolar changes.
Ages ranged from 1 to 18 years.
Figure 1. Details of the Clinical Spectrum
A, Acral erythema pattern on the dorsal side of the toes. B, Inflammation of 1 toe showing a dactylitis pattern. C, Moderate vasculitic-like lesions on the feet demonstrating a maculopapular purpuric pattern. D, Mixed pattern composed of dactylitis and purpuric maculopapules.
Figure 2. Main Histologic Features
A, Acral skin with moderate edema in the papillary dermis, perivascular/perieccrine lymphohistiocytic infiltrate, and lymphocytic vasculitis (hematoxylin-eosin). B, Severe perieccrine and deep perivascular infiltrate. Notice the presence of lymphocytic vasculitis as well as fibrin deposition in the vessel walls (hematoxylin-eosin).